Thoracic Neoplasm clinical trials

Explore recruiting thoracic neoplasm clinical trials.

Recruiting thoracic neoplasm studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Thoracic Neoplasm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Use of half the iodinated contrast medium for monitoring thoracic neoplasms using spectral CT: Randomized, crossover, non-inferiority clinical trial

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Thoracic Neoplasm trials by city

Thoracic Neoplasm in Toronto Thoracic Neoplasm in Vancouver Thoracic Neoplasm in Montreal Thoracic Neoplasm in Calgary Thoracic Neoplasm in Edmonton Thoracic Neoplasm in Ottawa Thoracic Neoplasm in Winnipeg Thoracic Neoplasm in Quebec City Thoracic Neoplasm in Hamilton Thoracic Neoplasm in Kitchener Thoracic Neoplasm in London Thoracic Neoplasm in Halifax Thoracic Neoplasm in New York Thoracic Neoplasm in Los Angeles Thoracic Neoplasm in Chicago Thoracic Neoplasm in Houston

Thoracic Neoplasm clinical trials

Recruiting thoracic neoplasm studies right now

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC

A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules

AB122 Platform Study

Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada

SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

A Confirmatory Clinical Study in NSCLC Patients With MET Exon 14 Mutation (KUNPENG-2)

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Also recruiting in Europe

Use of half the iodinated contrast medium for monitoring thoracic neoplasms using spectral CT: Randomized, crossover, non-inferiority clinical trial

Thoracic Neoplasm trials by city

Other conditions